Process for preparing cadaverine dicarboxylate
The microbial fermentation and conversion process for cadaverine dicarboxylate production addresses solubility and contamination issues by using diammonium dicarboxylate, achieving high-purity and high-yield cadaverine dicarboxylate without additional purification steps, enhancing efficiency and reducing environmental impact.
Patent Information
- Application Number
- PCT/KR2024/006739
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-07-31
- Filing Date
- 2024-05-17
- Publication Date
- 2025-01-02
AI Technical Summary
The production of cadaverine dicarboxylate, specifically cadaverine succinate and cadaverine glutarate, faces challenges due to high solubility in water leading to viscosity issues and low recovery rates, as well as contamination from unreacted dicarboxylic acids, which complicates crystallization and reduces purity, and requires additional processes for purification, increasing costs and environmental concerns.
A microbial fermentation process is used to produce lysine dicarboxylate, which is then converted to cadaverine dicarboxylate by adding dicarboxylic acid in the form of diammonium dicarboxylate, simplifying the process and eliminating the need for separate dicarboxylic acid removal, thereby achieving high-purity cadaverine dicarboxylate production without the need for additional purification steps.
This method results in high-yield, high-purity cadaverine dicarboxylate production, maintaining 99% purity and achieving yields of 80% or more through multiple cycles, without the need for decarboxylation and distillation processes, thus improving process efficiency and reducing environmental impact.
Smart Images

Figure KR2024006739_02012025_PF_FP_ABST
Abstract
Description
Cadaverine dicarboxylate manufacturing process
[0001] The present application relates to a technology for producing high-purity cadaverine dicarboxylate (cadaverine succinate or cadaverine glutarate) using a microbial fermentation and purification process.
[0002] Cadaverine is a toxic, foul-smelling diamine compound produced by the decomposition of animal tissue. Unlike hexanediamine, cadaverine exists in a liquid state at room temperature and readily absorbs carbon dioxide, an acidic gas in the air, making transportation and storage difficult. Therefore, salt-forming crystallization not only yields a high-quality monomer but also facilitates transportation and storage.
[0003] Meanwhile, cadaverine succinate, a monomer component of nylon 54, is a new type of bio-based nylon. It has a wide range of applications in medicine, agriculture, and industry, and is an environmentally friendly raw material. Furthermore, cadaverine glutarate is a highly industrially useful raw material used as a precursor for the production of polyamide resin.
[0004] The process for preparing cadaverine dicarboxylate generally includes the following steps:
[0005] Synthesis of Cadaverine: Cadaverine synthesis involves the fermentation of suitable microbial strains capable of producing lysine decarboxylase, an enzyme that catalyzes the decarboxylation of lysine to cadaverine.
[0006] Formation of cadaverine dicarboxylate: The formation of cadaverine dicarboxylate involves the reaction between cadaverine and a dicarboxylic acid in the presence of a suitable catalyst. The reaction typically involves mixing the two monomers at a suitable temperature and stirring for a specified period of time to ensure complete reaction.
[0007] Purification of cadaverine dicarboxylate: Once the reaction is complete, the raw material, cadaverine dicarboxylate, is purified using various separation and purification techniques such as solvent extraction, chromatography, and crystallization.
[0008] According to the prior art, cadaverine succinate or cadaverine glutarate also has high solubility in pure water, and the solubility increases significantly as the temperature increases. In addition, the high solubility causes high viscosity of the solution and shows a low recovery rate, making it difficult to crystallize cadaverine succinate in an aqueous system. In addition, there is a problem that unreacted succinic acid or unreacted glutaric acid, respectively, crystallizes together, lowering the purity of the final product, cadaverine succinate or cadaverine glutarate, and this must be removed before crystallization, which causes problems such as cost burden due to additional process for removal, decreased process efficiency, and environmental pollution due to the use of chemical solvents.
[0009] The problem to be solved by the present application is to provide a method for producing cadaverine dicarboxylate (cadaverine succinate or cadaverine glutarate).
[0010] One object of the present application is to provide a method for producing cadaverine dicarboxylate, comprising the first step of culturing an L-lysine producing microorganism in a medium to which dicarboxylic acid is added in the form of diammonium dicarboxylate to obtain lysine dicarboxylate, and the second step of converting the lysine dicarboxylate into cadaverine dicarboxylate.
[0011]
[0012] According to one aspect of the present application, by culturing an L-lysine-producing microorganism in a medium containing diammonium dicarboxylate to obtain lysine dicarboxylate and enzymatically converting the lysine dicarboxylate into cadaverine dicarboxylate, a separate process for removing the dicarboxylate is not required, thereby simplifying the process, and at the same time, high-purity C4 or C5 cadaverine dicarboxylate can be produced in high yield without dicarboxylic acid crystals being precipitated together as a byproduct.
[0013]
[0014] Figure 1 is a flowchart showing a process for manufacturing cadaverine dicarboxylate according to the present application.
[0015] Figure 2 is a flowchart showing a process for manufacturing cadaverine dicarboxylate according to one embodiment of the present application.
[0016] This is explained in detail as follows. Meanwhile, each description and embodiment disclosed in this application can also be applied to each other description and embodiment. In other words, all combinations of the various elements disclosed in this application fall within the scope of this application. Furthermore, the scope of this application is not limited by the specific descriptions described below.
[0017]
[0018] One aspect of the present application provides a method for producing cadaverine dicarboxylate, comprising a first step of culturing an L-lysine producing microorganism in a medium to which dicarboxylic acid is added in the form of diammonium dicarboxylate to obtain lysine dicarboxylate, and a second step of converting the lysine dicarboxylate into cadaverine dicarboxylate.
[0019]
[0020] In this application, the term "dicarboxylic acid" means a dibasic acid containing two carboxyl groups, and is highly important as a metabolic intermediate in the body. Specifically, the dicarboxylic acid may be an aliphatic dicarboxylic acid having 4 or 5 carbon atoms. That is, in this application, the dicarboxylic acid means one aliphatic dicarboxylic acid selected from succinic acid and glutaric acid. When the cadaverine dicarboxylate to be produced in the manufacturing method of the present application is cadaverine succinate, it should be understood that all of the added or introduced dicarboxylic acids are succinic acid, and further, when the cadaverine dicarboxylate to be produced in the manufacturing method of the present application is cadaverine glutarate, it should be understood that all of the added or introduced dicarboxylic acids are glutaric acid. Thus, in the present application, dicarboxylic acid is understood to refer to one type of aliphatic dicarboxylic acid, not a mixture of different types of dicarboxylic acids.
[0021]
[0022] The term "succinic acid" in this application refers to a four-carbon dicarboxylic acid with the chemical formula C4H6O4, which typically exists as a sour-tasting, odorless white solid. Succinic acid is also known as succinic acid, butanedioic acid, and succinic acid, and is utilized as a precursor for various industrial products, including polymers and plasticizers.
[0023] The term "glutaric acid" in this application refers to a dicarboxylic acid having five carbon atoms and a chemical formula of C5H8O4, which generally exists in the form of colorless crystals. Glutaric acid is also called 1,3-propanedicarboxylic acid, n-pyrotartaric acid, etc., and is utilized as a precursor for various industrial products, including polymers and plasticizers.
[0024]
[0025] The term "cadaverine (CAD)" in this application refers to a foul-smelling, toxic diamine compound with the chemical formula NH2(CH2)5NH2. Cadaverine may also be referred to as 1,5-pentanediamine or pentamethylenediamine. It should be understood that the term "cadaverine" in this application includes the cadaverine dicarboxylate salt form.
[0026] The term "cadaverine dicarboxylate" in this application refers to a substance prepared by reacting a dicarboxylic acid component with the diamine-type cadaverine, and has high industrial utility as a precursor for preparing polyamide resins. Specifically, the term "cadaverine dicarboxylate" in this application refers to a cadaverine dicarboxylate selected from cadaverine succinate and cadaverine glutarate.
[0027]
[0028] Figures 1 and 2 are flowcharts showing a process for manufacturing cadaverine dicarboxylate according to one embodiment of the present application.
[0029]
[0030] In this application, the term "L-lysine producing microorganism" includes both wild type microorganisms and microorganisms that have undergone natural or artificial genetic modification, and may be a microorganism that includes genetic modification for the production of L-lysine, as a microorganism whose specific mechanism has been weakened or strengthened due to causes such as insertion of an external gene or enhancement or inactivation of the activity of an endogenous gene.
[0031] In one example, the microorganism producing L-lysine of the present application may be, but is not limited to, a microorganism that naturally has L-lysine production ability, a microorganism that has L-lysine production ability conferred on a microorganism that does not have L-lysine production ability, or a microorganism that has significantly low L-lysine production ability enhanced with L-lysine production ability. Specifically, the microorganism producing L-lysine or the microorganism having L-lysine production ability of the present application may be a microorganism in which some of the genes in the L-lysine biosynthesis pathway are enhanced or weakened, or some of the genes in the L-lysine degradation pathway are enhanced or weakened. "Enhanced" or "increased" L-lysine production ability means that the L-lysine production ability is improved compared to a parent strain or an unmodified microorganism.
[0032] As a specific example, the microorganism may be a microorganism of the genus Corynebacterium or a microorganism of the genus Escherichia. The microorganism of the genus Corynebacterium may include all microorganisms belonging to the genus Corynebacterium. Specifically, Corynebacterium glutamicum, Corynebacterium crudilactis, Corynebacterium deserti, Corynebacterium efficiens, Corynebacterium callunae, Corynebacterium stationis, Corynebacterium singulare, Corynebacterium halotolerans, Corynebacterium striatum, Corynebacterium ammoniagenes, Corynebacterium pollutisoli pollutisoli), Corynebacterium imitans, Corynebacterium testudinoris or Corynebacterium flavescens, and more specifically, but not limited to, Corynebacterium glutamicum. Microorganisms of the genus Escheria may include all microorganisms belonging to the genus Escheria.Specifically, it may be Escherichia coli, Escherichia albertii, Escherichia blattae, Escherichia fergusonii, Escherichia hermannii or Escherichia vulneris, and more specifically, the strain of the genus Escherichia may be Escherichia coli, but is not limited thereto.
[0033] The above L-lysine-producing microorganism can be cultivated using suitable media and culture conditions known in the art. This cultivation process can be easily adjusted and used by those skilled in the art depending on the selected microorganism. Specifically, the cultivation may be batch, continuous, or fed-batch, but is not limited thereto.
[0034] In this application, the term "medium" refers to a material containing nutrients necessary for culturing the microorganism as a main component, and supplies nutrients and growth factors, including water, which is essential for survival and growth. Specifically, the medium used for culturing the L-lysine-producing microorganism of the present application may be any medium used for culturing general microorganisms without particular limitation, except that it contains diammonium dicarboxylate as part or all of the nitrogen source. The microorganism of the present application can be cultured under aerobic conditions while controlling temperature, pH, etc. in a general medium containing a nitrogen source including diammonium dicarboxylate, an appropriate carbon source, phosphorus, inorganic compounds, amino acids, and / or vitamins.
[0035]
[0036] The first step of the method for producing cadaverine dicarboxylate of the present application is a step of culturing an L-lysine-producing microorganism in a medium to which dicarboxylic acid is added in the form of diammonium dicarboxylate to obtain lysine dicarboxylate. This can be achieved through a fermentation process of the lysine-producing microorganism.
[0037]
[0038] In the first step, the dicarboxylic acid may be supplied to the medium in the form of diammonium dicarboxylate, and accordingly, it should be understood that the dicarboxylic acid in the present application includes the form of diammonium dicarboxylate.
[0039] The term "diammonium dicarboxylate" in this application refers to a form in which two hydrogen atoms of a dicarboxylic acid are replaced with ammonium, and is used as the main nitrogen source of the medium. The diammonium dicarboxylate may be prepared by gently mixing dicarboxylic acid with ammonia water to have a neutral pH, and then concentrated to form crystals or in liquid form, but is not limited thereto.
[0040]
[0041] The manufacturing method of the present application can manufacture cadaverine dicarboxylate with high purity while simplifying the process by adding 81 mol% or more of the dicarboxylic acid supplied throughout the process to the medium in the form of diammonium dicarboxylate in the first step, and can reduce the side effect of the dicarboxylate being precipitated together with cadaverine dicarboxylate.
[0042] Specifically, the diammonium dicarboxylate of the first step can be included in the medium at a high ratio, specifically 61 mol% or more, with respect to the dicarboxylic acid supplied throughout the entire process of the manufacturing method of the present application.
[0043] More specifically, the diammonium dicarboxylate of the first step may be included in 61 mol% or more, 68 mol% or more, 73 mol% or more, 81 mol% or more, 82 mol% or more, 83 mol% or more, 84 mol% or more, 85 mol% or more, 86 mol% or more, 87 mol% or more, 88 mol% or more, 89 mol% or more, 90 mol% or more, 91 mol% or more, 92 mol% or more, 93 mol% or more, 94 mol% or more, 95 mol% or more, 96 mol% or more, 97 mol% or more, 98 mol% or more, 99 mol% or more, or 100 mol% of the dicarboxylic acid supplied in the entire process of the manufacturing method of the present application.
[0044] The manufacturing method of the present application can provide the advantage of manufacturing high-purity cadaverine dicarboxylate by including a large amount of diammonium dicarboxylate in the medium, thereby eliminating the need for a separate dicarboxylate removal step, such as an ion resin exchange, decarboxylation process, or distillation process, unlike conventional processes that involve adding ammonium sulfate, etc. In addition, the use of diammonium dicarboxylate can facilitate the adjustment of the molar ratio of dicarboxylic acid added throughout the entire process / cadaverine in the process solution after the second step.
[0045]
[0046] Specifically, the diammonium dicarboxylate of the first step may be included so that the molar ratio (diammonium dicarboxylate / lysine) with respect to the lysine to be produced is 0.63 to 1. More specifically, the diammonium dicarboxylate of the first step may be included so that the molar ratio (diammonium dicarboxylate / lysine) with respect to the lysine to be produced is 0.6 to 0.98, 0.73 to 0.98, 0.78 to 0.98, or 0.8 to 0.98, or 0.83 to 0.98, and more specifically 0.85 to 0.98. At this time, it should be understood that the amount of lysine to be produced refers to the total amount including all forms of lysine dicarboxylate.
[0047] For example, the diammonium dicarboxylate of the first step may be included in a molar ratio (diammonium dicarboxylate / lysine) with the lysine to be produced in a range consisting of a lower limit selected from 0.63, 0.65, 0.7, 0.73, 0.78, 0.8, 0.85, 0.86, 0.87, 0.88, and 0.89 and / or an upper limit selected from 1, 0.99, 0.98, 0.97, 0.96, 0.95, 0.94, 0.93, and 0.92.
[0048]
[0049] Specifically, the diammonium dicarboxylate of the first step may be included in an amount of 0.4 mol / L to 0.8 mol / L based on the fermentation broth of the L-lysine-producing microorganism. More specifically, the diammonium dicarboxylate of the first step may be included in an amount of 0.48 mol / L to 0.7 mol / L, 0.5 mol / L to 0.7 mol / L, 0.55 mol / L to 0.7 mol / L, or 0.55 mol / L to 0.65 mol / L based on the fermentation broth of the L-lysine-producing microorganism. By adding the diammonium dicarboxylate at the above concentration, ammonium ions may act as a nitrogen source during fermentation, and dicarboxylic acid and lysine may form a salt and be included in a dissolved state in the fermentation broth.
[0050]
[0051] Lysine dicarboxylate can be produced through fermentation of L-lysine-producing microorganisms in a medium containing diammonium dicarboxylate. Lysine dicarboxylate can be introduced into a subsequent process as a fermentation broth containing the cells, in the form of a fermentation broth with the cells removed, or after purification.
[0052]
[0053] The concentration of lysine in the fermentation liquid in which the first-stage lysine-producing microorganism of the present application is cultured is not limited, but may be 90 g / L to 300 g / L, 92 g / L to 250 g / L, 92 g / L to 160 g / L, or 92 g / L to 100 g / L based on the fermentation liquid of the L-lysine-producing microorganism.
[0054]
[0055] The carbon source of the above medium may include carbohydrates such as glucose, fructose, sucrose, maltose, and their isomers; sugar alcohols such as mannitol and sorbitol; organic acids such as pyruvic acid, lactic acid, and citric acid; and amino acids such as glutamic acid, methionine, and lysine. In addition, natural organic nutrients such as starch hydrolysate, molasses, blackstrap molasses, rice winter, cassava, sugarcane bagasse, and corn steep liquor may be used, and specifically, carbohydrates such as glucose and sterilized pretreated molasses (i.e., molasses converted to reducing sugar) may be used, and other appropriate carbon sources may be used in various ways without limitation. These carbon sources may be used alone or in combination of two or more, but are not limited thereto.
[0056] As a specific example, the carbon source that may be included in the culture medium of the present application may include glucose, maltose, or maltose isomers. More specifically, the carbon source may include at least one selected from among glucose, maltose, and maltose isomers (isomaltose), or a combination of two or more thereof, but is not limited thereto.
[0057] The above-mentioned badge may include potassium phosphate monobasic, potassium phosphate dibasic, or their corresponding sodium-containing salts. Inorganic compounds may include sodium chloride, calcium chloride, iron chloride, magnesium sulfate, iron sulfate, manganese sulfate, calcium carbonate, and the like.
[0058] Additionally, the culture medium may contain metal salts, such as magnesium sulfate or iron sulfate, necessary for growth. Finally, in addition to the above substances, essential growth substances, such as amino acids and vitamins, may be used. Appropriate precursors may also be used in the culture medium. The above-mentioned raw materials may be added to the culture in an appropriate manner during the cultivation process, for example, batchwise or continuously, but are not limited thereto.
[0059] The nitrogen source of the above medium may include diammonium dicarboxylate. A typical medium for microbial culture may include an inorganic nitrogen source such as ammonia, ammonium sulfate, ammonium chloride, ammonium acetate, ammonium phosphate, ammonium carbonate, ammonium nitrate, etc. as a nitrogen source; an organic nitrogen source such as amino acids such as glutamic acid, methionine, glutamine, etc., peptone, NZ-amine, meat extract, yeast extract, malt extract, corn steep liquor, casein hydrolysate, fish or its decomposition product, defatted soybean cake or its decomposition product, etc. However, in one embodiment of the present application, diammonium dicarboxylate may be included as the sole nitrogen source or as an additional nitrogen source.
[0060]
[0061] After the first step of producing lysine dicarboxylate by culturing an L-lysine producing microorganism in a medium containing diammonium dicarboxylate, a second step of converting the lysine dicarboxylate into cadaverine dicarboxylate can be performed.
[0062]
[0063] The second step refers to the step of converting lysine dicarboxylate into the target product, cadaverine dicarboxylate (cadaverine succinate or cadaverine glutarate).
[0064]
[0065] In one specific embodiment, the second step may further comprise adding a dicarboxylic acid to the process liquid. The process liquid may be the fermentation process liquid obtained in the first step.
[0066] The dicarboxylic acid added in the second step may not be added or may be added in a trace amount of 0.45 mol / L or less, 0.31 mol / L or less, 0.18 mol / L or less, 0.15 mol / L or less, 0.12 mol / L or less, 0.1 mol / L or less, 0.08 mol / L or less, 0.05 mol / L or less, 0.04 mol / L or less, 0.03 mol / L or less, 0.02 mol / L or less, or 0.01 mol / L or less based on the volume of the fermentation process liquid obtained in the first step.
[0067] In one specific example, when the dicarboxylic acid is succinic acid, the dicarboxylic acid added in the second step may not be added or may be added in a trace amount of 0.15 mol / L or less.
[0068] In one specific example, when the dicarboxylic acid is glutaric acid, the dicarboxylic acid added in the second step may not be added or may be added in a trace amount of 0.08 mol / L or less.
[0069]
[0070] When dicarboxylic acid is additionally added to the process solution in the second step, the dicarboxylic acid may be added before, after, or simultaneously with the conversion reaction, but is not limited thereto.
[0071] If dicarboxylic acid is additionally added in the second step, it is understood that the amount of dicarboxylic acid added throughout the process of the manufacturing method of the present application is the sum of the amount of diammonium dicarboxylate added to the medium in the first step and the amount of dicarboxylic acid added in the second step. In addition, if dicarboxylic acid is not additionally added to the process solution in the second step, it is understood that the amount of dicarboxylic acid added throughout the process of the manufacturing method of the present application is the same as the amount of diammonium dicarboxylate added to the medium in the first step.
[0072]
[0073] Specifically, the amount of dicarboxylic acid added in the present application's manufacturing method may be added taking into account the amount of cadaverine in the process liquid obtained after the second step. Specifically, the amount of dicarboxylic acid added in the present application's manufacturing method may be a molar ratio of 0.85 to 1.10 relative to the amount of cadaverine in the process liquid obtained after the second step.
[0074] More specifically, the amount of dicarboxylic acid added in the present application manufacturing method may be a molar ratio of 0.85 to 1.07, 0.87 to 1.06, 0.88 to 1.05, 0.89 to 1.03, 0.88 to 1.02, 0.89 to 1.0, 0.9 to 1.10, 0.93 to 1.08, 0.93 to 1.07, 0.95 to 1.06, or 0.95 to 1.05 relative to the amount of cadaverine in the process solution after the second step.
[0075] For example, the amount of dicarboxylic acid added in the present application manufacturing method may be included in a molar ratio in a range consisting of one lower limit selected from 0.83, 0.84, 0.85, 0.86, 0.87, 0.88, 0.89, 0.9, 0.91, 0.92, 0.93, 0.94, and 0.95 and / or one upper limit selected from 1.10, 1.09, 1.08, 1.07, 1.06, 1.05, 1.04, 1.03, 1.02, 1.01, and 1.0 relative to the amount of cadaverine in the process solution after the second step.
[0076]
[0077] In one specific example, when the dicarboxylic acid is succinic acid, the amount of the dicarboxylic acid added in the manufacturing method of the present application may be a molar ratio of 0.9 to 1.10, 0.91 to 1.09, 0.92 to 1.08, 0.93 to 1.07, 0.94 to 1.06, or 0.95 to 1.05 relative to the amount of cadaverine in the process solution after the second step.
[0078] One technical significance of the present invention lies in the discovery that when succinic acid is added in a molar ratio within the above range in comparison with the amount of cadaverine calculated to be obtained after the second step in the manufacturing method of the present application, succinic acid does not crystallize together with cadaverine succinate, thereby enabling the production of cadaverine succinate with high purity and high yield.
[0079] In addition, by adjusting the molar ratio of the cadaverine to be obtained and the succinic acid to be added, it is possible to maintain the purity of cadaverine succinate at 99% up to the fourth cycle during the circulation of the mother liquor, and cadaverine succinate can be obtained at a total yield of 30% or more, 32% or more, 51% or more, 53% or more, 65% or more, 68% or more, 75% or more, 78% or more, 80% or more, 81% or more, 82% or more, 83% or more, 84% or more, or 85% or more depending on the number of cycles of the mother liquor.
[0080] In one specific example, when the dicarboxylic acid is glutaric acid, the amount of the dicarboxylic acid added in the manufacturing method of the present application may be a molar ratio of 0.8 to 1.05, 0.83 to 1.04, 0.85 to 1.03, 0.87 to 1.02, 0.88 to 1.01, or 0.89 to 1.0 relative to the amount of cadaverine in the process solution after the second step.
[0081] One technical significance of the present invention lies in the discovery that when glutaric acid is added in a molar ratio within the above range in comparison with the amount of cadaverine calculated to be obtained after the second step in the manufacturing method of the present application, glutaric acid does not crystallize together with cadaverine glutarate, thereby enabling the production of high-purity and high-yield cadaverine succinate.
[0082] In addition, by adjusting the molar ratio of the cadaverine to be obtained and the glutaric acid to be added, it is possible to maintain the purity of cadaverine glutarate at 99% up to the third cycle during the circulation of the mother liquor, and cadaverine glutarate can be obtained at a total yield of 50% or more, 49% or more, 50% or more, 52% or more, 74% or more, 75% or more, 77% or more, 86% or more, 87% or more, 88% or more, 92% or more, 93% or more, or 94%, depending on the number of cycles of the mother liquor.
[0083]
[0084] In the second step, the conversion reaction of the lysine dicarboxylate to cadaverine dicarboxylate may be an enzymatic conversion reaction.
[0085] In one specific example, the lysine dicarboxylate may include both the lysine dicarboxylate obtained in the first step and the lysine dicarboxylate produced in the second step when a dicarboxylic acid is additionally added in the second step.
[0086]
[0087] Specifically, the enzymatic conversion reaction of the second step can be performed using a protein having lysine decarboxylase activity or a microorganism expressing a protein having the activity.
[0088] As a specific example, a protein having lysine decarboxylase activity may be added to the fermentation process liquid of the first stage, or a starter culture of a microorganism expressing a protein having the activity may be added, but is not limited thereto.
[0089]
[0090] The term "decarboxylase" in this application refers to an enzyme that catalyzes the production of carbonic acid by removing a carboxyl group, which is an organic acid, and may also be named decarboxylase, decarboxylase, decarboxylase, decarboxylase, or carbonic acid decarboxylase.
[0091] The above protein is not particularly limited as long as it exhibits lysine decarboxylase activity, but may be, for example, PtLDC protein from Pseudomonas thermotolerans or CadA protein derived from Escherichia coli. However, the protein sequence may be obtained using GenBank, a known database, or expressed using the above microorganism, or a commercially available enzyme may be purchased and used, and is not limited thereto.
[0092] The microorganism expressing the above protein may be a microorganism transformed to express the protein. The transformed microorganism is not limited to a prokaryotic microorganism or a eukaryotic microorganism, as long as it is transformed to express a protein having decarboxylase activity. The microorganism transformed to express the protein having decarboxylase activity can convert lysine dicarboxylate in the process solution into cadaverine dicarboxylate by secreting the protein having the enzymatic activity into the starter culture solution.
[0093] Specific examples thereof may include strains of Escherichia, Erwinia, Serratia, Providencia, and coryneform microorganisms. The microorganism may specifically be a microorganism belonging to the genus Escherichia or the genus Corynebacterium, and more specifically, may be, but is not limited to, Escherichia coli or Corynebacterium glutamicum.
[0094]
[0095] The conversion reaction of the second step may be performed for 20 minutes to 3 hours, more specifically for 0.5 to 1.5 hours, and for example, for 1 hour, but is not limited thereto.
[0096] The conversion reaction of the second step may be performed at 30 to 60°C, more specifically at 40 to 50°C, and for example, at 45°C, but is not limited thereto.
[0097]
[0098] The conversion reaction of the second step may be performed at a pH of 7.5 to 9, more specifically at a pH of 7.8 to 8.7, and even more specifically at a pH of 8 to 8.5. In one embodiment of the second step, the pH may be adjusted to the above range by optionally adding a dicarboxylic acid, and in another embodiment, the pH may be adjusted to the above range by adding CO2. When the pH range of the second step conversion reaction is adjusted to the above range, the conversion rate of lysine dicarboxylate to cadaverine dicarboxylate may be significantly increased.
[0099]
[0100] The method for producing cadaverine dicarboxylate of the present application may further include a recovery step of recovering the obtained cadaverine dicarboxylate after performing the second step.
[0101]
[0102] The above recovery may be by collecting cadaverine dicarboxylate using a suitable method known in the art.
[0103] For example, cadaverine dicarboxylate can be collected by various chromatographic methods such as centrifugation, filtration, concentration, crystallization, extraction, ultrasonic disruption, ultrafiltration, dialysis, molecular sieve chromatography (gel filtration), adsorption chromatography, ion exchange chromatography, affinity chromatography, HPLC, or a combination of these methods.
[0104]
[0105] In one specific embodiment of the present application, the recovery step may include one or more of a filtration step, a concentration step, and a crystallization step.
[0106]
[0107] The above filtration step refers to a step of removing impurities from the conversion solution containing cadaverine dicarboxylate obtained in the second step. As an example, the filtration may include removing cells in the cadaverine dicarboxylate process solution by performing membrane separation, etc., or performing activated carbon filtration, etc.
[0108] The above concentration step refers to a step of concentrating to increase the solid content ratio in the conversion solution, and may be performed after the filtration step. As an example, the concentration may be performed by reducing pressure concentration using a rotary evaporator.
[0109] Specifically, the above concentration step may be to concentrate so that the solid content becomes 70 to 85% (w / w), and more specifically, to concentrate so that it becomes 73 to 85% (w / w), 75 to 82% (w / w), 70 to 80% (w / w), 75-85% (w / w), 74-83% (w / w), 78-82% (w / w), or 73-77% (w / w), and for example, to concentrate so that it becomes 75% (w / w). When the solid content is concentrated in the above range in the above concentration step, the recovery rate and purity of cadaverine dicarboxylate can be excellently maintained.
[0110] The above concentration step may be performed at, but is not limited to, 45 to 65°C.
[0111]
[0112] The above crystallization step may be a cooling crystallization step, which means a step of cooling the conversion solution and precipitating it into crystals to obtain the final target product, cadaverine dicarboxylate crystals.
[0113] Specifically, the cooling may be cooling the conversion solution to 20 to 30°C, more specifically to 23 to 27°C, and for example to 25°C, but is not limited thereto.
[0114] Specifically, the cooling rate may be 5-20°C / hour, more specifically 5-15°C / hour, and for example, 10°C / hour, but is not limited thereto.
[0115]
[0116] In one embodiment, the recovery step may further include a stirring step for stirring the process solution. The stirring step may be performed simultaneously with the cooling crystallization step, during the cooling crystallization step, before the cooling crystallization step, or after the cooling crystallization step. This stirring step provides sufficient time for the process solution to be stirred, thereby facilitating crystal precipitation.
[0117]
[0118] In one embodiment, the recovery step may further include a mother liquor circulation step of recycling the mother liquor containing non-crystallized cadaverine dicarboxylate after the crystallization step to the feed liquor of the concentration step.
[0119] Specifically, in the mother liquor circulation step, the number of times the mother liquor is cycled may be 0 to 3 times, 1 to 3 times, 1 to 4 times, 1 to 5 times, 1 to 10 times, or more. In this case, a number of times the mother liquor is cycled being 0 means that the mother liquor circulation step is not performed.
[0120]
[0121] In the past, there was a problem that a relatively large amount of cadaverine dicarboxylate still remained in the mother liquor remaining after crystallization in the step of crystallizing cadaverine dicarboxylate, resulting in a low yield of less than 50%. In the present application, as a method for improving the yield of cadaverine dicarboxylate, the total yield of cadaverine dicarboxylate can be increased by recycling the remaining mother liquor of cadaverine dicarboxylate as a feed liquid of the concentration step 1 to 3 times, 1 to 4 times, 1 to 5 times, 1 to 10 times or more.
[0122]
[0123] In one embodiment, the recovery step may further include washing, separating, and drying the crystallized process solution.
[0124] In the above drying step, moisture contained in the crystals is removed through drying, and a high-purity cadaverine dicarboxylate can be commercialized. After drying, the cadaverine dicarboxylate crystals can be provided in powder form, but the formulation can be varied as needed.
[0125]
[0126] In one embodiment, the recovery step may further include a decolorization step. The decolorization may be performed using, but is not limited to, activated carbon, anion resin, or the like.
[0127]
[0128] Additionally, the method for producing cadaverine dicarboxylate of the present application may include an additional purification step. The purification may be performed using any suitable method known in the art. In one example, when the method for producing cadaverine dicarboxylate of the present application includes both a recovery step and a purification step, the recovery process and the purification process may be performed continuously or discontinuously, regardless of the order, or may be performed simultaneously or integrated into a single step, but is not limited thereto.
[0129]
[0130] The manufacturing method of the present application may be characterized by not including a separate process for removing the dicarboxylate salt in the recovery step. In the case of the conventional cadaverine dicarboxylate production process, the dicarboxylate salt precipitates as crystals together during the crystallization process, lowering the purity. To prevent this, a separate process for removing the dicarboxylate salt before crystallization was required. However, the manufacturing method of the present application provides the technical advantage of producing high-purity cadaverine dicarboxylate salt without performing a separate dicarboxylate salt removal process.
[0131]
[0132] In one embodiment, when the dicarboxylic acid is succinic acid, the method of the present application may be characterized in that cadaverine succinate having a purity of 99% or higher can be obtained in the 0th to 4th cycle of the mother liquor. In one embodiment, when the dicarboxylic acid is succinic acid, based on the 4th cycle of the mother liquor, the accumulated total yield of cadaverine succinate may be greater than 80%, and more specifically, may be 81% or higher, 82% or higher, 83% or higher, or 84% or higher.
[0133] In one embodiment, when the dicarboxylic acid is glutaric acid, the method of the present application may be characterized in that cadaverine glutarate having a purity of 99% or higher can be obtained in the 0th to 3rd cycle of the mother liquor. In one embodiment, when the dicarboxylic acid is glutaric acid, the accumulated total yield of cadaverine glutarate may be greater than 90%, and more specifically, may be 92% or higher, 93% or higher, or 94% or higher, based on the 3rd cycle of the mother liquor.
[0134]
[0135] The method of the present application can produce high-purity cadaverine dicarboxylate without the decarboxylation and distillation processes required in the conventional liquid cadaverine production.
[0136] The present application will be described in more detail below through examples. However, the following examples are merely preferred embodiments intended to illustrate the present application and are therefore not intended to limit the scope of the present application. Furthermore, technical details not described herein can be readily understood and implemented by those skilled in the technical field of the present application or similar fields.
[0137]
[0138] The above has described a process for manufacturing cadaverine dicarboxylate (cadaverine succinate or cadaverine glutarate) according to one embodiment of the present application. Below, the advantageous effects mentioned in the present application will be examined through experimental results of examples and comparative examples of cadaverine succinate or cadaverine glutarate, respectively.
[0139]
[0140] Manufacturing Example 1. Manufacturing of cadaverine succinate
[0141] Manufacturing Example 1-1. Fermentation process for producing lysine succinate
[0142] A Corynebacterium glutamicum strain (KCCM12154P, US Patent Publication No. US 2021-0355514 A1) capable of producing lysine was cultured on solid surfaces and in flasks to obtain seed cultures. After seed culture in a fermenter, the main production fermentation was performed. Fermentation was performed at 36°C for 30 hours, with the fermenter cultured at 900 rpm.
[0143] To produce lysine succinate using Corynebacterium, diammonium succinate was supplied at a level of 76 to 99 g / L to replace the existing ammonium sulfate, and as a result of fermentation, lysine succinate at a level of 132 to 172 g / L and lysine at a level of 99 g / L were obtained. At this time, the molar ratio of succinic acid / lysine in the fermentation process solution in the example was adjusted to a level of 0.74 to 0.96.
[0144]
[0145] Manufacturing Example 1-2. Conversion reaction of lysine succinate to cadaverine succinate
[0146] For the conversion reaction, E. coli (US Patent Publication No. US 2018-0030430 A1) overexpressing the PtLDC enzyme, a lysine decarboxylase gene derived from Pseudomonas thermotolerans, using the pET-Deut1 vector was used.
[0147] The enzyme conversion solution obtained by culturing the above enzyme strain in the fermentation process solution of lysine succinate prepared from the above Manufacturing Example 1-1 was supplied at a level of 10% by mass percentage to the process solution to perform the conversion reaction. The conversion reaction temperature was maintained at 45 to 50°C and performed for approximately 1 hour. The pH was adjusted to 8.0 to 8.5, and for this purpose, in the cases of the following Examples 1-1 to 1-3, CO2 was added for neutralization, and in the cases of Examples 1-1 and 1-3, dicarboxylic acid was additionally added at a level of 0.03 mol / L (based on the volume of the fermentation process solution of lysine succinate). As a result, it was confirmed that the conversion rate of cadaverine succinate was at the level of 97 to 98%. Specifically, after the conversion reaction, cadaverine succinate was obtained at a level of 117 to 143 g / L (based on the volume of the fermentation process solution of lysine succinate), and cadaverine was obtained at a level of 68 g / L (based on the volume of the fermentation process solution of lysine succinate). In the cases of Examples 1-4 to 1-7, succinic acid was additionally added at a level of 0.02 to 0.15 mol / L to prepare the process solution.
[0148]
[0149] Manufacturing Example 1-3. Subsequent processes after obtaining cadaverine succinate
[0150] The following subsequent process was performed on the process solution containing cadaverine succinate obtained in Manufacturing Example 1-2 to obtain cadaverine succinate in crystal form.
[0151]
[0152] [Bacterial removal step]
[0153] The cells in the cadaverine succinate process solution were removed by performing membrane filtration with a size of 0.1 μm.
[0154] [Step to remove impurities using activated carbon]
[0155] Activated carbon was added at a level of 10% based on the weight of cadaverine succinate in the filtrate from which the cells were separated. The process solution with activated carbon added was heated to 60°C and stirred for 1 hour to decolorize, and then the activated carbon was filtered through a filter paper.
[0156] [Step of concentrating the cadaverine succinate process solution from which impurities have been removed]
[0157] The filtered liquid above was concentrated under reduced pressure at about 45-65°C and 40-70 torr in a rotary evaporator until the solid content of the filtrate became 75-82% by weight.
[0158] [Step of cooling, crystallizing, and separating the cadaverine succinate concentrate and then drying it]
[0159] The above concentrate was cooled from 45-35°C to 25°C at a rate of 5°C / hr. The precipitated crystals were separated from the mother liquor using a centrifuge. The crystals were washed with water containing 10% of the weight of cadaverine succinate. The separated crystals were dried for one day, and their purity was measured by HPLC.
[0160] [Step of recycling the mother liquor to the crystallization stage]
[0161] The mother liquor separated above was recycled to the [step of concentrating the cadaverine succinate process solution from which impurities have been removed].
[0162]
[0163] Experimental Example 1. Confirmation of changes in the purity and yield of cadaverine succinate according to the molar ratio of succinic acid and cadaverine.
[0164] In Experimental Example 1, the method according to Manufacturing Examples 1-1 to 1-3 was used, and it was confirmed how the purity and yield of cadaverine succinate changed depending on the molar ratio of succinic acid added throughout the entire process and cadaverine in the process solution after the second step.
[0165]
[0166] Example 1-1: When the molar ratio of succinic acid added / cadaverine in the process solution after the second step is 0.8
[0167] 1,000 ml of a cadaverine succinate conversion solution having a succinic acid / cadaverine molar ratio of 0.8 was supplied and passed through a 0.1 μm membrane to remove microorganisms. The cadaverine succinate conversion solution having a succinic acid / cadaverine molar ratio of 0.8 was manufactured by following the manufacturing methods of Manufacturing Examples 1-1 and 1-2, except that the sum of the amount of diammonium succinate added in the fermentation process for producing lysine in Manufacturing Example 1-1 and the amount of succinic acid added in the cadaverine succinate conversion reaction in Manufacturing Example 1-2 (limited to the case of the example in which succinic acid was additionally added in the second step) was controlled to be 0.8 of the mole number of cadaverine that was converted.
[0168] The filtrate was decolorized using activated carbon, filtered through a filter paper, and concentrated under reduced pressure at 40 torr to a solid content of 78% by weight. The concentrate was cooled from 35°C to 25°C to crystallize. The crystals and mother liquor were separated by centrifugation, and the separated crystals were dried for one day and their purity was measured by HPLC. The mother liquor containing residual succinate was recycled to the cadaverine succinate feed solution having a succinic acid / cadaverine molar ratio of 0.8, and then concentrated again. The recycling of the mother liquor was performed sequentially.
[0169]
[0170] Example 1-2: When the molar ratio of added succinic acid / cadaverine in the process solution after the second step is 0.9
[0171] A cadaverine succinate conversion solution having a succinic acid / cadaverine molar ratio of 0.9 was supplied, and the mother liquor was sequentially recycled and a purification process was performed in the same manner as in Example 1-1.
[0172]
[0173] Example 1-3: When the molar ratio of added succinic acid / cadaverine in the process solution after the second step is 0.95
[0174] A cadaverine succinate conversion solution having a succinic acid / cadaverine molar ratio of 0.95 was supplied, and the mother liquor was sequentially recycled and a purification process was performed in the same manner as in Example 1-1.
[0175]
[0176] Example 1-4: When the molar ratio of added succinic acid / cadaverine in the process solution after the second step is 1.01
[0177] A cadaverine succinate conversion solution having a succinic acid / cadaverine molar ratio of 1.01 was supplied, and the mother liquor was sequentially recycled and a purification process was performed in the same manner as in Example 1-1.
[0178]
[0179] Example 1-5: When the molar ratio of added succinic acid / cadaverine in the process solution after the second step is 1.05
[0180] A cadaverine succinate conversion solution having a succinic acid / cadaverine molar ratio of 1.05 was supplied, and the mother liquor was sequentially recycled and a purification process was performed in the same manner as in Example 1-1.
[0181] For Examples 1-3 to 1-5, the molar ratio of succinic acid / lysine in the lysine fermentation step was adjusted to 0.88-0.96.
[0182]
[0183] Example 1-6: When the molar ratio of added succinic acid / cadaverine in the process solution after the second step is 1.10
[0184] A cadaverine succinate conversion solution having a succinic acid / cadaverine molar ratio of 1.10 was supplied, and the mother liquor was sequentially recycled and a purification process was performed in the same manner as in Example 1-1.
[0185]
[0186] Example 1-7: When the molar ratio of added succinic acid / cadaverine in the process solution after the second step is 1.20
[0187] A cadaverine succinate conversion solution having a succinic acid / cadaverine molar ratio of 1.20 was supplied, and the mother liquor was sequentially recycled and a purification process was performed in the same manner as in Example 1-1.
[0188]
[0189] The physical property measurements for the process solutions and cadaverine succinate prepared according to the above-described Examples 1-1 to 1-7 are as shown in Tables 1 to 5 below.
[0190]
[0191] Table 1 shows the process solution that did not circulate the mother liquor.
[0192] No mother liquor circulation Example 1-1 Example 1-2 Example 1-3 Example 1-4 Example 1-5 Example 1-6 Example 1-7 Succinic acid / cadaverine molar ratio 0.8 0.9 0.9 5 1.0 1 1.0 5 1.1 1.2 Crystallization feed New feed ml 1000 1000 1000 1000 1000 1000 1000 Amount of cadaverine in crystallization solution, g 36 236 236 236 236 236 2 Amount of cadaverine in produced crystals, g 87 103 110 116 109 1038 9 Amount of cadaverine in mother liquor, g 27 5 259 252 246 253 259 273 Resulting purity, %99.099.099.099.099.099.088.5 Yield, %24.128.530.332.030.228.424.7 Total Yield, %24.128.530.332.030.228.424.7
[0193] Table 2 shows the process solution that has been circulated once.
[0194] Mother liquor circulation 1 timeExample 1-1Example 1-2Example 1-3Example 1-4Example 1-5Example 1-6Example 1-7Succinic acid / cadaverine molar ratio0.80.90.951.011.051.11.2Crystallization feed solutionNew feed solution ml1000100010001000100010001000Amount of cadaverine in crystallization solution, g637621614608615621635Amount of cadaverine in produced crystals, g147173185195184172158Amount of cadaverine in mother liquor, g490448430414431449477Result purity, %99.099.099.099.099.099.088.7 Yield, %23.027.930.032.029.927.824.8 Total Yield, %41.648.551.353.851.048.243.4
[0195] Table 3 shows the process solution that was cycled twice.
[0196] Mother liquor circulation 2 timesExample 1-1Example 1-2Example 1-3Example 1-4Example 1-5Example 1-6Example 1-7Succinic acid / cadaverine molar ratio0.80.90.951.011.051.11.2Crystallization feed solutionNew feed solution ml1000100010001000100010001000Amount of cadaverine in crystallization solution, g852810792776793811839Amount of cadaverine in produced crystals, g186221235248234219209Amount of cadaverine in mother liquor, g666589557527559591630Result purity, %99.099.099.099.099.099.088.9 Yield, %21.927.229.732.029.527.124.9 Total Yield, %54.462.565.768.665.562.257.5
[0197] Table 4 shows the process solution after circulating the mother liquor three times.
[0198] Mother liquor circulation 3 timesExample 1-1Example 1-2Example 1-3Example 1-4Example 1-5Example 1-6Example 1-7Succinic acid / cadaverine molar ratio0.80.90.951.011.051.11.2Crystallization feed solutionNew feed solution ml10001000100010001000100010001000Amount of cadaverine in crystallization solution, g1028951919889921953992Amount of cadaverine in produced crystals, g212252269285268251247Amount of cadaverine in mother liquor, g816699649605654703745Result purity, %99.099.099.099.099.098.689.0 Yield, %20.626.529.332.029.026.324.9 Total Yield, %63.872.475.878.675.572.268.1
[0199] Table 5 shows the process solution after circulating the mother liquor four times.
[0200] Mother liquor circulation 4 timesExample 1-1Example 1-2Example 1-3Example 1-4Example 1-5Example 1-6Example 1-7Succinic acid / cadaverine molar ratio0.80.90.951.011.051.11.2Crystallization feed solutionNew feed solution ml1000100010001000100010001000Amount of cadaverine in crystallization solution, g117810611011967101610651107Amount of cadaverine in generated crystals, g227272292309290274276Amount of cadaverine in mother liquor, g950789720657726791831Result purity, %99.099.099.099.099.098.189.0 Yield, %19.325.728.832.028.525.724.9 Total Yield, %70.879.582.885.582.579.376.0
[0201] By summarizing the experimental results according to Tables 1 to 5 above, it was confirmed that the presently applied manufacturing method, which includes a large amount of diammonium succinate in the first step at 81-100 mol% of the total supplied succinic acid, enables the production of cadaverine succinate with an overall improved crystallization rate, high purity, and high yield.
[0202]
[0203] More specifically, Example 1-1 had a high purity of 99% but a low yield of 70.8% when the mother liquor was cycled four times. This is because the sequentially circulated mother liquor lowered the molar ratio of succinate to the crystallization feed, and the concentration of succinate was insufficient compared to the concentration of cadaverine succinate.
[0204] Example 1-2 had a high purity of 99% when the mother liquor was cycled four times, but a somewhat low yield of 79.5%. This was because the sequentially circulated mother liquor lowered the molar ratio of succinate to the crystallization feed, and the concentration of succinate was insufficient compared to the concentration of cadaverine succinate.
[0205]
[0206] On the other hand, Example 1-3 has a high purity of 99% and a high total yield of 82.8% when the mother liquor is processed 4 times.
[0207] Example 1-4 shows a high purity of 99% and a high total yield of 85.5% when the mother liquor is run 4 times.
[0208] Example 1-5 shows a high purity of 99% and a high total yield of 82.5% when the mother liquor is run four times.
[0209]
[0210] Example 1-6 had a somewhat low purity of 98.1% when the mother liquor was used for the fourth time, but a somewhat low yield of 79.3%. This was because succinic acid exceeding the solubility was precipitated as crystals, lowering the purity.
[0211] Example 1-7 had a low purity of 89% when the mother liquor was used for the fourth time, but a low yield of 76%. This is because succinic acid exceeding the solubility was precipitated as crystals, lowering the purity.
[0212]
[0213] In this way, it was found that a method for producing high-purity cadaverine succinate can be provided depending on the molar ratio of succinic acid added throughout the entire process relative to the amount of cadaverine in the process solution after the second step. In particular, it was confirmed that when the amount of succinic acid added was adjusted to a molar ratio of about 0.95 to 1.05 relative to the amount of cadaverine in the process solution after the second step, an excellent total yield of 82% or more could be achieved while maintaining a purity of 99% of cadaverine succinate even after four or more cycles of mother liquor circulation.
[0214]
[0215] Manufacturing Example 2. Manufacturing of cadaverine glutarate
[0216] Manufacturing Example 2-1. Fermentation process for producing lysine glutarate
[0217] A Corynebacterium glutamicum strain (KCCM12154P, Publication No. US 2021-0355514 A1) capable of producing lysine was cultured on solid surfaces and in flasks to obtain seed cultures. After seed culture in a fermenter, the main production fermentation was performed. Fermentation was performed at 36°C for 30 hours, with the fermenter cultured at 900 rpm.
[0218] To produce lysine glutarate using Corynebacterium, diammonium glutarate was supplied at a level of 66 to 100 g / L to replace the existing ammonium sulfate, and as a result of fermentation, lysine glutarate at a level of 111 to 167 g / L and lysine at a level of 92 g / L were obtained. At this time, the glutaric acid / lysine molar ratio in the fermentation process liquid in the example was adjusted to a level of 0.63 to 0.95.
[0219]
[0220] Manufacturing Example 2-2. Conversion reaction of lysine glutarate to cadaverine glutarate
[0221] For the conversion reaction, E. coli (US Patent Publication No. US 2018-0030430 A1) overexpressing the PtLDC enzyme, a lysine decarboxylase gene derived from Pseudomonas thermotolerans, using the pET-Deut1 vector was used.
[0222] The enzyme conversion solution obtained by culturing the enzyme strain above was supplied to the fermentation process solution of lysine glutarate prepared from the above Manufacturing Example 2-1 at a mass percentage of 10% to the process solution to perform the conversion reaction. The conversion reaction temperature was maintained at 45 to 50°C and performed for approximately 1 hour. The pH was adjusted to 8.0 to 8.5, and for this purpose, in the cases of Examples 2-1 to 2-4, CO2 was added for neutralization, and in the cases of Examples 2-1 to 2-3 and 2-4, dicarboxylic acid was additionally added at a level of 0.01 to 0.05 mol / L (based on the volume of the fermentation process solution of lysine glutarate). As a result, it was confirmed that the conversion rate of cadaverine glutarate was at the level of 97 to 98%. Specifically, after the conversion reaction, cadaverine succinate was obtained at a level of 101 to 141 g / L (based on the volume of the fermentation process solution of lysine glutarate), and cadaverine was obtained at a level of 63 g / L (based on the volume of the fermentation process solution of lysine glutarate). In the cases of Examples 2-4 to 2-7, glutaric acid was additionally added at a level of 0.02 to 0.08 mol / L to prepare the process solution.
[0223]
[0224] Manufacturing Example 2-3. Subsequent processes after obtaining cadaverine glutarate
[0225] The following subsequent process was performed on the process solution containing cadaverine glutarate obtained in Manufacturing Example 2-2 to obtain cadaverine glutarate in crystal form.
[0226] [Bacterial removal step]
[0227] The cells in the cadaverine glutarate process solution were removed by performing membrane filtration with a size of 0.1 μm.
[0228] [Step to remove impurities using activated carbon]
[0229] Activated carbon was added at a level of 10% based on the weight of cadaverine glutarate in the filtrate from which the cells were separated. The process solution with activated carbon added was heated to 60℃ and stirred for 1 hour to decolorize, and then the activated carbon was filtered through a filter paper.
[0230] [Step of concentrating the cadaverine glutarate process solution from which impurities have been removed]
[0231] The filtered liquid above was concentrated under reduced pressure at about 45-65°C and 40-70 torr in a rotary evaporator until the solid content of the filtrate became 75-82% by weight.
[0232] [Step of cooling, crystallizing, and separating the cadaverine glutarate concentrate and then drying it]
[0233] The above concentrate was cooled from 50-35°C to 25°C at a rate of 5°C / hr. The precipitated crystals were separated from the mother liquor using a centrifuge. The crystals were washed with 10% water based on the weight of cadaverine glutarate. The separated crystals were dried for one day, and their purity was measured by HPLC.
[0234] [Step of recycling the mother liquor to the crystallization stage]
[0235] The mother liquor separated above was recycled to the [step of concentrating the cadaverine glutarate process solution from which impurities have been removed].
[0236]
[0237] Experimental Example 2. Confirmation of changes in cadaverine glutarate purity and yield according to the molar ratio of glutarate and cadaverine.
[0238] In Experimental Example 2, the method according to Manufacturing Examples 2-1 to 2-3 was used, and it was confirmed how the purity and yield of cadaverine glutarate changed depending on the molar ratio of glutaric acid added throughout the entire process and cadaverine in the process solution after the second step.
[0239]
[0240] Example 2-1: When the molar ratio of added glutaric acid / cadaverine in the process solution after the second step is 0.7
[0241] 1,000 ml of a cadaverine glutarate conversion solution having a glutarate / cadaverine molar ratio of 0.7 was supplied and passed through a 0.1 μm membrane to remove microorganisms. The cadaverine glutarate conversion solution having a glutarate / cadaverine molar ratio of 0.7 was manufactured by following the manufacturing methods of Manufacturing Examples 2-1 and 2-2, except that the sum of the amount of ammonium glutarate added in the fermentation process for producing lysine in Manufacturing Example 2-1 and the amount of glutaric acid added in the cadaverine glutarate conversion reaction in Manufacturing Example 2-2 (limited to the case of the example in which glutaric acid was additionally added in the second step) was controlled to be 0.7 of the mole number of cadaverine that was converted.
[0242] The filtrate was decolorized using activated carbon, filtered through a filter paper, concentrated under reduced pressure at 40 torr, and concentrated to a solid content of 75% by weight. The concentrate was cooled from 50°C to 25°C and crystallized. The crystals and mother liquor were separated by centrifugation, and the separated crystals were dried for one day and their purity was measured by HPLC. The mother liquor containing residual glutarate was recycled to a cadaverine glutarate feed solution having a glutaric acid / cadaverine molar ratio of 0.7, and then concentrated again. The recycling of the mother liquor was performed sequentially.
[0243]
[0244] Example 2-2: When the molar ratio of added glutaric acid / cadaverine in the process solution after the second step is 0.79
[0245] A cadaverine glutarate conversion solution having a glutaric acid / cadaverine molar ratio of 0.79 was supplied, and the mother liquor was sequentially recycled and a purification process was performed in the same manner as in Example 2-1.
[0246]
[0247] Example 2-3 When the molar ratio of added glutaric acid / cadaverine in the process solution after the second step is 0.89
[0248] A cadaverine glutarate conversion solution having a glutaric acid / cadaverine molar ratio of 0.89 was supplied, and the mother liquor was sequentially recycled and a purification process was performed in the same manner as in Example 2-1.
[0249]
[0250] Example 2-4: When the molar ratio of added glutaric acid / cadaverine in the process solution after the second step is 0.95
[0251] A cadaverine glutarate conversion solution having a glutaric acid / cadaverine molar ratio of 0.95 was supplied, and the mother liquor was sequentially recycled and a purification process was performed in the same manner as in Example 2-1.
[0252]
[0253] Example 2-5: When the molar ratio of added glutaric acid / cadaverine in the process solution after the second step is 1.0
[0254] A cadaverine glutarate conversion solution having a glutarate / cadaverine molar ratio of 1.0 was supplied, and the mother liquor was sequentially recycled and a purification process was performed in the same manner as in Example 2-1.
[0255] For Examples 2-3 to 2-5, the molar ratio of glutaric acid / lysine in the lysine fermentation step was adjusted to 0.79-0.95.
[0256]
[0257] Example 2-6: When the molar ratio of added glutaric acid / cadaverine in the process solution after the second step is 1.05
[0258] A cadaverine glutarate conversion solution having a glutarate / cadaverine molar ratio of 1.05 was supplied, and the mother liquor was sequentially recycled and a purification process was performed in the same manner as in Example 2-1.
[0259]
[0260] Example 2-7: When the molar ratio of added glutaric acid / cadaverine in the process solution after the second step is 1.10
[0261] A cadaverine glutarate conversion solution having a glutarate / cadaverine molar ratio of 1.1 was supplied, and the mother liquor was sequentially recycled and a purification process was performed in the same manner as in Example 2-1.
[0262]
[0263] The physical property measurements for the process solution and cadaverine glutarate prepared according to Examples 2-1 to 2-7 described above are as shown in Tables 6 to 9 below.
[0264]
[0265] Table 6 is for the process solution that did not circulate the mother liquor.
[0266]
[0267] No mother liquor circulation Example 2-1 Example 2-2 Example 2-3 Example 2-4 Example 2-5 Example 2-6 Example 2-7 Glutaric acid / cadaverine molar ratio 0.70 0.79 0.89 0.95 1.00 1.05 1.10 Crystallization feed New feed ml 1000 1000 1000 1000 1000 1000 1000 Amount of cadaverine in crystallization solution, g 3 2 7 3 2 7 3 2 7 3 2 7 3 2 7 Amount of cadaverine in produced crystals, g 1 4 1 1 5 3 1 6 2 1 6 6 1 7 0 1 6 6 1 Amount of cadaverine in mother liquor, g 1 8 6 1 7 4 5 1 6 1 1 5 7 1 6 1 1 6 6 Result Purity, %99.099.099.099.099.095.090.0Yield, %43.046.849.750.952.050.649.3Total Yield, %43.046.849.750.952.050.649.3
[0268] Table 7 shows the process solution that has been circulated once.
[0269] Mother liquor circulation 1 timeExample 2-1Example 2-2Example 2-3Example 2-4Example 2-5Example 2-6Example 2-7Glutaric acid / cadaverine molar ratio0.700.790.890.951.001.051.10Crystallization feed solutionNew feed solution ml10001000100010001000100010001000Amount of cadaverine in crystallization solution, g513501492488484488493Amount of cadaverine in produced crystals, g208226240246252248246Amount of cadaverine in mother liquor, g305275251241232240247Result purity, %99.099.099.099.099.095.390.8 Yield, %40.645.248.950.552.050.950.0 Total Yield, %66.170.874.375.777.075.874.6
[0270] Table 8 shows the process solution that was circulated twice.
[0271] Mother liquor circulation 2 timesExample 2-1Example 2-2Example 2-3Example 2-4Example 2-5Example 2-6Example 2-7Glutaric acid / cadaverine molar ratio0.700.790.890.951.001.051.10Crystallization feed solutionNew feed solution ml1000100010001000100010001000Amount of cadaverine in crystallization solution, g632602578568559567574Amount of cadaverine in produced crystals, g238260277284291289289Amount of cadaverine in mother liquor, g394342301284268278284Result purity, %99.099.099.099.099.095.491.3 Yield, %37.743.247.950.052.051.050.4 Total Yield, %78.983.486.687.988.988.187.4
[0272] Table 9 shows the process solution after circulating the mother liquor three times.
[0273] Mother liquor circulation 3 timesExample 2-1Example 2-2Example 2-3Example 2-4Example 2-5Example 2-6Example 2-7Glutaric acid / cadaverine molar ratio0.700.790.890.951.001.051.10Crystallization feed solutionNew feed solution ml1000100010001000100010001000Amount of cadaverine in crystallization solution, g721669628611595605611Amount of cadaverine in produced crystals, g248273293302310309310Amount of cadaverine in mother liquor, g473396335309286296301Result purity, %99.099.099.099.099.095.591.6 Yield, %34.340.746.649.452.051.150.7 Total Yield, %86.190.292.893.994.794.293.8
[0274] In summary of the experimental results according to Tables 6 to 9 above, it was confirmed that the present application's manufacturing method, which includes a large amount of diammonium glutarate in the first step at a level of 88-100 mol% of the total glutaric acid supplied, enables the production of cadaverine glutarate with an overall improved crystallization rate, high purity, and high yield.
[0275]
[0276] More specifically, Example 2-1 had a high purity of 99% but a low yield of 86.1% when the mother liquor was cycled three times. This is because the sequentially circulated mother liquor lowered the molar ratio of glutarate to the crystallization feed, and the concentration of glutarate was insufficient compared to the concentration of cadaverine glutarate.
[0277] Example 2-2 has a high purity of 99% and a high yield of 90.2% when the mother liquor is processed three times.
[0278]
[0279] Meanwhile, Example 2-3 has a high purity of 99% and a high yield of 92.8% when the mother liquor is used for the third time.
[0280] Example 2-4 has a high purity of 99% and a high total yield of 93.9% when the mother liquor is run for the third time.
[0281] Example 2-5 has a high purity of 99% and a high total yield of 94.7% when the mother liquor is processed three times.
[0282]
[0283] Example 2-6 had a low purity of 95.5% and a yield of 94.2% when the mother liquor was run for the third time. This was because glutaric acid exceeding the solubility was precipitated as crystals, lowering the purity, and the concentration was insufficient compared to that of cadaverine glutarate.
[0284] Example 2-7 had a lower purity and a slightly lower yield of 93.8% compared to Example 3 (91.6%) when the mother liquor was used for the third time. This was because glutaric acid exceeding the solubility was precipitated as crystals, lowering the purity, and the concentration of cadaverine glutarate was insufficient.
[0285]
[0286] In this way, it was found that a method for producing high-purity cadaverine glutarate can be provided depending on the molar ratio of glutaric acid added throughout the entire process relative to the amount of cadaverine in the process solution after the second step. In particular, it was confirmed that when the amount of added glutaric acid was adjusted to a molar ratio of about 0.89 to 1.0 relative to the amount of cadaverine in the process solution after the second step, an excellent total yield of 92% or more could be achieved while maintaining a purity of 99% of cadaverine glutarate even after three or more cycles of mother liquor circulation.
[0287]
[0288] From the above description, those skilled in the art will understand that the present application can be implemented in other specific forms without altering its technical concept or essential characteristics. In this regard, it should be understood that the embodiments described above are illustrative in all respects and not restrictive. The scope of this application should be interpreted to include all changes or modifications derived from the meaning and scope of the following claims and their equivalents, rather than the detailed description above.
Claims
1. A first step of culturing an L-lysine producing microorganism in a medium containing dicarboxylic acid in the form of diammonium dicarboxylate to obtain lysine dicarboxylate; and A method for producing cadaverine dicarboxylate, comprising a second step of converting lysine dicarboxylate into cadaverine dicarboxylate, The amount of dicarboxylic acid added is 0.85 to 1.07 molar ratio to the amount of cadaverine in the process solution after the second step, The above dicarboxylic acid is an aliphatic dicarboxylic acid having 4 or 5 carbon atoms. Method for preparing cadaverine dicarboxylate.
2. In paragraph 1, A method for producing cadaverine dicarboxylate, wherein the diammonium dicarboxylate of the first step is comprised of 81 mol% or more of the total supplied dicarboxylic acid.
3. In paragraph 1, A method for producing cadaverine dicarboxylate, wherein the diammonium dicarboxylate of the first step is included so that the molar ratio (diammonium dicarboxylate / lysine) with the lysine to be produced is 0.78 to 0.
98.
4. A method for producing cadaverine dicarboxylate, wherein the conversion reaction of the second step in the first paragraph is performed at a pH of 8.0 to 8.
5.
5. In paragraph 1, The above dicarboxylic acid is succinic acid, A method for producing cadaverine dicarboxylate, wherein the amount of dicarboxylic acid added is a molar ratio of 0.95 to 1.05 relative to the amount of cadaverine in the process solution after the second step.
6. In paragraph 1, The above dicarboxylic acid is glutaric acid, A method for producing cadaverine dicarboxylate, wherein the amount of dicarboxylic acid added is a molar ratio of 0.89 to 1.0 relative to the amount of cadaverine in the process solution after the second step.
7. In paragraph 1, A method for producing cadaverine dicarboxylate, wherein the second step further comprises adding a dicarboxylic acid to the process solution.
8. In paragraph 1, A method for producing cadaverine dicarboxylate, further comprising a recovery step of recovering cadaverine dicarboxylate after performing the second step.
9. In paragraph 7, A method for producing cadaverine dicarboxylate, wherein the recovery step comprises at least one step selected from the group consisting of a filtration step, a concentration step, and a cooling crystallization step.
10. In paragraph 7, the recovery step is A method for producing cadaverine dicarboxylate, further comprising a mother liquor circulation step of recycling the mother liquor containing non-crystallized cadaverine dicarboxylate after the cooling crystallization step as a feed liquid of a concentration step.
11. A method for producing cadaverine dicarboxylate, wherein in the 8th paragraph, the concentration step is performed to concentrate the solid content to 75 to 82% (w / w).
12. In paragraph 1, A method for producing cadaverine dicarboxylate, wherein in the second step, converting lysine dicarboxylate into cadaverine dicarboxylate is performed using a protein having lysine decarboxylase activity or a microorganism expressing a protein having the activity.
13. In paragraph 1, A method for producing cadaverine dicarboxylate, wherein the above L-lysine producing microorganism is Corynebacterium glutamicum.
14. A method for producing cadaverine dicarboxylate, characterized in that the recovery step in the first paragraph does not include a separate process for removing dicarboxylate from the process solution.
15. In Article 9, The above dicarboxylic acid is succinic acid, A method for producing cadaverine dicarboxylate, wherein cadaverine dicarboxylate having a purity of 99% or higher can be obtained in the 0th to 4th cycle of the above-mentioned mother liquor.
16. In paragraph 9, The above dicarboxylic acid is glutaric acid, A method for producing cadaverine dicarboxylate, wherein cadaverine dicarboxylate having a purity of 99% or higher can be obtained in the 0th to 3rd cycle of the above-mentioned mother liquor.
Citation Information
Patent Citations
Novel lysine decarboxylase, and method for producing cadaverine by using same
US20180030430A1
Modified polypeptide with attenuated activity of citrate synthase and method for producing l-amino acid using the same
US20210355514A1
Method for producing cadaverine dicarboxylate and its use for the production of nylon
EP1482055A1
Method for producing aqueous cadaverine salt solution, cadaverine salt solution, cadaverine salt, polyamide resin, and molding
JP2008189661A
Cadaverine for polyamide raw material
JP2009028045A
